Medications
Wegovy, Zepbound, compounded lozenges and drops
Monthly Cost
$199-$499
Speed to Start
Fast
Est. 2022
About Shed
Shed entered the GLP-1 telehealth market in 2022 with one of the most distinctive value propositions we have reviewed: a 10% weight loss guarantee and unique medication formats including lozenges and liquid drops. The platform offers both brand-name medications (Wegovy and Zepbound) and compounded formulations, with monthly pricing between $199 and $499. The upper end of that range places Shed among the pricier options, but the weight loss guarantee and novel delivery methods add value that standard injectable-only providers do not offer.
Trust metrics are strong. Shed holds a 4.6 rating on Trustpilot across 830+ reviews, a score that reflects high patient satisfaction at a meaningful volume. The B BBB rating is solid, indicating responsible business practices and adequate complaint resolution. Together, these metrics place Shed in the high-trust category by our evaluation standards, a designation that carries weight in a market where many providers struggle with public perception.
The lozenge and liquid drop formulations are Shed’s most innovative feature. While the vast majority of GLP-1 telehealth providers offer only injectable semaglutide or tirzepatide, Shed provides compounded alternatives in formats that do not require needles. For the significant population of patients who experience needle anxiety, injection site reactions, or simply prefer oral administration, these alternative delivery methods remove a major barrier to treatment adherence. The lozenges dissolve sublingually, and the liquid drops offer precise dose control — both designed to maintain therapeutic efficacy while improving the patient experience.
The 10% body weight loss guarantee is a bold commitment that very few competitors are willing to make. While the specific terms and conditions of the guarantee should be reviewed carefully before enrollment, the willingness to stake business outcomes on clinical results signals confidence in the treatment protocols. This guarantee also aligns financial incentives between provider and patient in a way that fee-for-service models do not — Shed is motivated to ensure patients actually lose weight, not just maintain a subscription. The clinical support model is medium-tier with standard provider consultations and progress monitoring.
Shed’s main drawback is pricing. At 9-9/month, the platform is accessible at the low end but premium at the top. Patients opting for brand-name Wegovy or Zepbound through Shed will likely pay toward the upper range, while compounded lozenges and drops fall lower. The medium-support model also means patients do not receive the dietitian access or intensive coaching available at some competitors. However, for patients who specifically want non-injectable GLP-1 options or are motivated by the weight loss guarantee, Shed offers something genuinely unique in the current telehealth landscape.
At a Glance
Medications Offered
Wegovy, Zepbound, compounded lozenges and drops
Both
Cost & Insurance
- Monthly: $199-$499
- 6-month estimate: $1,194-$2,994
- Insurance: No
- Self-pay: Yes
Clinical Features
- Lab testing: No
- Dietitian access: No
- Verified Pharmacy: Not disclosed; offers unique lozenge and liquid drop formats
- BBB Rating: B
Delivery & Access
- Format: Both (Subcutaneous, Lozenge, Drops)
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Not available
What the Shed Intake Looks Like
We walked through Shed’s GLP-1 weight-loss intake ourselves. Shed inverts the typical telehealth flow — clinical screening happens BEFORE account creation, and the auth itself is passwordless (Google, Apple, or magic-link email). The cost structure is also unusual: a $125/month Shed Membership for unlimited provider access is paid separately from the medication itself.
Solid coverage of FDA-black-box, gallbladder, kidney, and a thoughtful side-effect tolerance triad (frequency, worry, daily-life impact). MEN is named without type-2 specificity. Family vs personal thyroid cancer are separate options. Missing eating disorder, mental health, substance use, allergies, and current-medication review.
Heavy on testimonials and marketing interstitials (-60 lbs and -70 lbs before-and-afters mid-flow, 4-step “What happens next” infographic, projection chart). Auth is modern and low-friction. Pricing is two-part: $125/month Shed Membership PLUS the medication cost paid separately to a third-party pharmacy.
The 13 Stages
Shed is unusual in the catalog: the patient walks through service selection, body metrics, the entire medical history multi-select, side-effect tolerance, GLP-1 recency, and the compounded-reason questions BEFORE being asked to create an account at screen 12. Auth itself is passwordless — Continue with Google, Continue with Apple, or Continue with email (magic link). This inverts the gated-funnel pattern most platforms use, where the account is created up-front to lock in the lead before clinical questions. Shed treats the medical questionnaire as the qualifier, with the account as the persistence layer once the patient is approved.
Shed’s pricing structure is unusual. The platform charges a $125/month Shed Membership at checkout for unlimited virtual provider visits, health coaching, weight-loss education, and Shed community access. The medication cost is separate and billed by a third-party dispensing pharmacy. The disclaimer is explicit: “Shed is not a pharmacy and does not dispense medications. Prescriptions for brand-name medications are typically sent to manufacturer-supported pharmacies, which often offer the most competitive cash-pay pricing. Patients may request that their prescription be sent to another pharmacy when available.” A patient on Wegovy® injections at $349/mo would pay $349 + $125 = $474/mo total. The compounded options (semaglutide $175/mo, tirzepatide $245/mo) appear to bundle the membership.
Shed adds a screen most platforms skip: a three-question side-effect tolerance assessment. How often do you experience side effects when taking medications (regularly/sometimes/never), do you worry about side effects like nausea, fatigue, vomiting, constipation, or diarrhea (Y/N), and how impactful would those side effects be on your daily life (very/somewhat/not impactful). For a medication class where GI side effects are the leading reason patients discontinue, asking about psychological readiness up-front is a thoughtful clinical addition.
No validated mental-health or PHQ instrument, no suicidality. No eating-disorder screen. No substance or alcohol screen. No general allergy capture outside the compounded-reason multi-select. No current-medication review. No pregnancy or breastfeeding screen. No blood pressure or resting heart rate. No diet history depth. The MEN entry is named without “type 2” specificity, so it’s unclear whether the question covers the FDA black-box scope precisely. No ID upload and no phone OTP.
Source: GLP-1.Reviews editorial walkthrough on April 29, 2026. We completed every screen of the Shed weight-loss intake using a representative GLP-1 candidate persona and stopped before submitting the $125 membership payment.
Opens shed.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
Start your GLP-1 weight loss journey with Shed today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
